Squamous cell carcinoma of the lip often develops from a precancerous lesion called actinic cheilitis. Both conditions can cause changes in the color and texture of your lip. Your outlook is best with ...

Ruxolitinib (a JAK2 inhibitor) and belumosudil (a ROCK2 inhibitor) have recently been approved by the Food and Drug Administration (FDA) for the treatment of chronic graft-versus-host disease (GVHD).

A study supports targeted conversion of kidney transplant recipients with a history of cutaneous squamous cell carcinoma ...

Medicus Pharma Ltd. has announced that its Investigational New Animal Drug for a dissolvable Doxorubicin-containing microneedle array (D-MNA) has received Minor Use in Major Species Designation (MUMS) ...